3rd Annual MarketsandMarkets Infectious Disease and Molecular Diagnostics Conference

23rd - 24th March 2022 | Millennium Gloucester Hotel London Kensington
Sponsors
Platinum

Co-Diagnostics Inc.

Co-Diagnostics Inc.

Co-Diagnostics develops innovative solutions for detection of infectious disease, liquid biopsy for cancer screening, and agribio applications. Our proprietary CoPrimer technology excels in disease detection, multiplexing, and life sciences research through enhanced detection of genetic material. Our EIKON At Home and Point of Care platform is designed to provide fast, inexpensive and accurate PCR test results, utilizing proprietary chemistry and instrumentation as we continue to grow our menu and expand our international footprint, currently servicing over 50 countries.

Silver

LumiraDx

LumiraDx

LumiraDx is transforming healthcare with fast, accurate and comprehensive diagnostics at the point of need. With the LumiraDx Platform, and Fast Lab Solutions unit, LumiraDx supports diagnostic needs across settings; from the lab, to hospitals, the physician’s office, the workplace, and schools. Founded in 2014, LumiraDx is based in the UK with R&D and manufacturing sites across the US and Europe.


AusDiagnostics

AusDiagnostics

AusDiagnostics is a manufacturer and supplier of highly multiplexed, automated molecular assays for the detection of pathogens and antibiotic resistance markers (respiratory including  Sars-Cov 2,  enteric, STIs,  HPV etc) from a wide range of clinical samples.

Key advantages of our approach are low cost, ease of use and a unique MT-PCR process that preserves the quantitative relationship between pathogens in the original sample. Our system  is coupled with easy to use software and we can supply equipment and IVD kits for laboratories of all sizes.

 

Visiting Partners

Avacta

Avacta

Our mission is to develop high-performance Affimer®-based diagnostics to improve health outcomes.

Utilising our proprietary Affimer® platform we are developing an in-house pipeline of IVD tests, starting with the AffiDX® SARS-CoV-2 Antigen Lateral Flow Test. The Affimer® platform is an alternative to antibodies derived from a small human protein.

We also work with IVD companies world-wide to improve the clinical utility of diagnostic testing solutions, by combining bespoke Affimer® reagents with leading diagnostic platform technologies.


BioMérieux

BioMérieux

A global leader of IVD for more than 50 years, bioMérieux continues to play a pioneering role by providing high medical value diagnostics to aid clinical decisions.  BioFire® FilmArray® is our innovative rapid syndromic diagnostic solution for Meningitis/Encephalitis, Respiratory and Gastrointestinal disease and Blood stream Infections.  With comprehensive results provided in around an hour, BioFire testing assists with patient management decisions in a clinically relevant time-frame.


Veracyte

Veracyte

Veracyte is a global diagnostics company that improves patient care by informing diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our extensive biorepositories, immuno-oncology biomarker testing and analytical services help our biopharmaceutical partners to advance their therapeutic discovery, development and commercialization programs.
 


OLM Dx

OLM Dx

OLM Diagnostics are acting to address the threat of fungal  infections,  our  research  and  development  drives  our  company  focus  to  enhance  our  reputation as a trusted healthcare partner and to enhance patient health outcomes. Our novel and reliable diagnostic tests fit seamlessly into current treatment pathways and can reduce the  rate  of  drug  resistant  infections  by  promoting  a  new  diagnostic  led  approach. 

Speaking Partner

miDiagnostics

miDiagnostics

miDiagnostics is a medical devices company active in the development of a new generation diagnostic platform for point-of-care testing based on disruptive nano-fluidic semi-conductor technology. The technology platform has the potential to miniaturize and simplify the diagnostics process, leading to a significant cost reduction and hence enabling true point-of-care diagnostics. The company succeeded in the development of a rapid PCR test for SARS-CoV-2, providing PCR accuracy whilst being as fast as rapid antigen tests.

Exhibition Partner

Novacyt Group

Novacyt Group

At Novacyt Group, we pride ourselves in concentrating our expertise on specific market needs, offering a comprehensive portfolio of quality products, backed by proven supply and delivery services, to ensure the highest possible standards of customer service around the world. Our passion is for customer-centric solutions that advance the science behind diagnostics. This fuels our drive to deliver products that save lives and help in the fight against infectious disease.

Find out more at www.novacyt.com


QuantuMDx

QuantuMDx

QuantuMDx is passionate about empowering the world to control disease and reduce suffering.

 QuantuMDx solves real-world diagnostic problems by creating multiplex molecular solutions for the Point of Need, for anyone, anywhere.

 Q-POC™ is a rapid, simple to use, portable, sample to answer multiplex PCR device. It’s been designed for use in a range of real-world settings, including hospitals, clinics, pharmacies, dentistry, workplaces and in the field, providing accurate PCR results at the Point of Need.

 


Pro-Lab Diagnostics

Pro-Lab Diagnostics

Pro-Lab Diagnostics specialise in the development, manufacture, and distribution of In Vitro Diagnostics kits and reagents as well as automated specialist equipment for the Biomedical Science Industry.  We are pleased to support the congress and share details of our products including one of the most comprehensive ranges of RT-PCR kits currently available, Viasure, V-Lab and V-Flex.  We are also looking to further discuss our work in the field of NGS.